Citation: D. Sayar et al., Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: A new concept, PED HEM ONC, 18(8), 2001, pp. 509-518
Authors:
Karmazyn, B
Ash, S
Goshen, Y
Yaniv, I
Horev, G
Kornreich, L
Citation: B. Karmazyn et al., Significance of residual abdominal masses in children with abdominal Burkitt's lymphoma, PEDIAT RAD, 31(11), 2001, pp. 801-805
Authors:
Blau, O
Avigad, S
Stark, B
Benyaminy, H
Luria, D
Kodman, Y
Cohen, IJ
Goshen, Y
Yaniv, I
Zaizov, R
Citation: O. Blau et al., p53 mutation in intron 6 as a diagnostic marker for high risk childhood T-lineage acute lymphoblastic leukemia, INT J PED H, 6(5), 2000, pp. 361-367
Authors:
Shuper, A
Stark, B
Kornreich, L
Cohen, IJ
Aviner, S
Steinmetz, A
Stein, J
Goshen, Y
Yaniv, I
Citation: A. Shuper et al., Methotrexate treatment protocols and the central nervous system: Significant cure with significant neurotoxicity, J CHILD NEU, 15(9), 2000, pp. 573-580
Authors:
Gavriel, H
Shuper, A
Kornreich, L
Goshen, Y
Yaniv, I
Cohen, IJ
Citation: H. Gavriel et al., Diffuse intrinsic brainstem disease with neurologic deterioration: Not what it seemed, MED PED ONC, 34(3), 2000, pp. 213-214
Authors:
Avigad, S
Kuperstein, G
Zilberstein, J
Liberzon, E
Stark, B
Gelernter, I
Kodman, Y
Luria, D
Ash, S
Stein, J
Goshen, Y
Yaniv, I
Cohen, IJ
Zaizov, R
Citation: S. Avigad et al., TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia, LEUKEMIA, 13(3), 1999, pp. 481-483